BS
Bharat Sandhal
About Bharat Sandhal
Data last updated:
Bharat Sandhal is a Director at Prowest Pharma Private Limited (since 2021), Director at Prowest Diagnostics Private Limited (since 2021) and Director at Hudson Square Pharma Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Trading, Healthcare and Business Outsourcing. The 4 current companies with reported revenue have a combined latest revenue of ₹2.78 Cr; the largest is Prowest Pharma Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Sep 2021 | 2021 | ₹1.38 Cr (FY 2025) | Active | |
| Director | 22 Sep 2021 | 2021 | ₹98.6 Lakh (FY 2025) | Active | |
| Director | 08 Sep 2021 | 2021 | ₹35.5 Lakh (FY 2023) | Active | |
| Director | 12 Dec 2021 | 2021 | ₹5.5 Lakh (FY 2025) | Active |
Board colleagues of Bharat Sandhal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harpreet Singh Jolly | 05327917 | Prowest Pharma Private Limited , Prowest Diagnostics Private Limited and 1 more | Director |
| Neeraj Gupta | 09311504 | Hudson Square Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharat Sandhal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Sandhal
Bharat Sandhal currently holds 4 directorships: Prowest Pharma Private Limited (Director, since 22 Sep 2021, revenue ₹1.38 Cr (FY 2025)); Prowest Diagnostics Private Limited (Director, since 22 Sep 2021, revenue ₹98.6 Lakh (FY 2025)); Hudson Square Pharma Private Limited (Director, since 08 Sep 2021, revenue ₹35.5 Lakh (FY 2023)); Triton Settlerz Visa Experts Private Limited (Director, since 12 Dec 2021, revenue ₹5.5 Lakh (FY 2025)).
Bharat Sandhal was first appointed on 08 Sep 2021 as Director at Hudson Square Pharma Private Limited.
The 4 current companies of Bharat Sandhal that report revenue have a combined latest revenue of ₹2.78 Cr: Prowest Pharma Private Limited ₹1.38 Cr (FY 2025); Prowest Diagnostics Private Limited ₹98.6 Lakh (FY 2025); Hudson Square Pharma Private Limited ₹35.5 Lakh (FY 2023); Triton Settlerz Visa Experts Private Limited ₹5.5 Lakh (FY 2025).
The current boards of Bharat Sandhal's companies include Harpreet Singh Jolly (Prowest Pharma Private Limited), Neeraj Gupta (Hudson Square Pharma Private Limited).